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Brown adipose tissueIn this studywe show thatmitochondrial uncoupling protein 1 (UCP1) in brown adipose tissue (BAT) and thymus
mitochondria can be ubiquitinylated and degraded by the cytosolic proteasome. Using a ubiquitin conjugating
system, we show that UCP1 can be ubiquitinylated in vitro. We demonstrate that UCP1 is ubiquitinylated in vivo
using isolated mitochondria from brown adipose tissue, thymus and whole brown adipocytes. Using an in vitro
ubiquitin conjugating–proteasome degradation system, we show that the cytosolic proteasome can degrade
UCP1 at a rate commensurate with the half-life of UCP1 (i.e. 30–72 h in brown adipocytes and ~3 h, in
thymocytes). In addition, we demonstrate that the cytoplasmic proteasome is required for UCP1 degradation
from mitochondria that the process is inhibited by the proteasome inhibitor MG132 and that dissipation of the
mitochondrial membrane potential inhibits degradation of UCP1. There also appears to be a greater amount of
ubiquitinylated UCP1 associated with BAT mitochondria from cold-acclimated animals. We have also identiﬁed
(using immunoprecipitation coupled with mass spectrometry) ubiquitinylated proteins with molecular masses
greater than 32 kDa, as being UCP1. We conclude that there is a role for ubiquitinylation and the cytosolic protea-
some in turnover ofmitochondrial UCP1. This article is part of a Special Issue entitled: 17th European Bioenergetics
Conference (EBEC 2012).
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial uncoupling protein 1 (UCP1) is present in brown
adipose tissue (BAT) [1,2] and thymus mitochondria [3–5]. Uncou-
pling protein 1 (UCP1) is a 32 kDa tripartitemitochondrial carrier pro-
tein of 306 amino acids. The amino acid sequence of UCP1 is highly
similar to that of several ubiquitous mitochondrial inner-membrane
carriers, including the adenine nucleotide carrier (ANT) [6]. In the
thymus, UCP1 has a role in thymocyte selection and proliferation by
an unidentiﬁed mechanism [7]. In BAT, UCP1 uncouples mitochondria
in response to cold exposure [1,2] resulting in increased oxygen
consumption and heat production by that tissue, a process termed
non-shivering thermogenesis. Essentially, noradrenaline signals
through the β3-adrenoreceptor in order to activate UCP1 and through
other adrenoreceptors (α1 and α2) that activate other signaling path-
ways [1,2,8]. The β-adrenergic receptors in BAT have been indirectlyopean Bioenergetics Conference
munology, Room 6.08, Trinity
arse Street, Dublin 2, Ireland.
rights reserved.shown to be coupled to adenylate cyclase [9]. As in other tissues,
cAMP interacts with protein kinase A activating it which in turn
further phosphorylates a series of targets to propagate the adrenergic
signal. The cAMP response element-binding protein is one such target
which, when phosphorylated, stimulates transcription of the UCP1
gene [10]. The half-life of UCP1 in BAT is relatively long with a range of
half-lives reported in the literature, from 20 h for acute adrenergically
stimulated brown adipocytes, to 30 h reported for UCP1 expressed in
CHO cells [11], 72 h for chronic adrenergically stimulated brown
adipocytes [12] and up to 3.5 days reported in non-noradrenaline stimu-
lation of cells in primary cultures [13]. Furthermore, in regard to protein
turnover, UCP1 degradation in BAT has only ever been described in the
context of lysosomal degradation [12].
We recently identiﬁed serine phosphorylation of UCP1 in BAT
mitochondria, the proportion of which is augmented following cold-
acclimation [14]. Phosphorylation has been identiﬁed as a ﬂag for
ubiquitinylation [15,16]. In our endeavours to investigate the role of
serine phosphorylation of UCP1, we set out to determine whether
UCP1 turnover may be linked to ubiquitinylation and proteasomal
degradation as has been described for UCP2 in insulinoma cells and
UCP3 in myotubules [17] (reviewed in [18]).
Ubiquitin is a highly conserved 76 amino acid polypeptide that is
abundant in all eukaryotic cells. Ubiquitinylation involves the covalent
1760 K.J. Clarke et al. / Biochimica et Biophysica Acta 1817 (2012) 1759–1767attachment of a ubiquitin molecule or a chain of ubiquitin molecules
(polyubiquitinylation) to a lysine residue of a target protein. Like phos-
phorylation, ubiquitinylation is a reversible process due to the activity
of deubiquitinylating enzymes [19]. The attachedmolecule or chain can
affect the localization, activity, structure or interaction partners of the
target protein. One of the main functions of ubiquitinylation is to target
a protein for degradation by the cytosolic 26S proteasome [20,21].
Ubiquitin conjugation occurs through a three-step process involving
three enzymes E1-3. E1 is a ubiquitin-activating enzyme, which
through anATP-dependent reaction is linked by a high-energy thioester
bond to ubiquitin. The ubiquitin is then transferred in a second thioester
linkage to a ubiquitin-conjugation enzyme (E2) which catalyzes the
transfer of ubiquitin to the substrate protein in a covalent bond. A ubi-
quitin ligase (E3) is required to transfer the activated ubiquitin to the
substrate protein. Ubiquitin transfer to the target protein occurs by
linkage of the α-carboxyl group glycine of ubiquitin to a lysine ε-amino
group on the target protein [21]. It has been shown that Lys48-linked
polyubiquitinylationation is a signal for proteasomal degradation by the
26S proteasome, whereas other types of ubiquitinylationation such as
Lys63-linkedmono-ubiquitination are involved in non-degradation regu-
lation of proteins.
Until recently it was not known whether mitochondrial proteins
were subject to ubiquitinylation. ATP-dependent proteases such as
the Lon and the Clp proteases were thought to be the main participants
in the degradation of mitochondrial proteins [22]. However recent
reports suggest that ubiquitinylation may play an important role in mi-
tochondrial protein quality control [23,24]. Over 60 ubiquitinylated
mitochondrial proteins have been identiﬁed including prohibitin of
mammalian sperm [25], and the oligomycin sensitive conferring
protein (OSCP) subunit of mitochondrial F1F0 ATPase [23]. Indirect
evidence obtained using proteasome inhibitors has also supported a
role for a ubiquitin dependent protein quality control system in mito-
chondria [23]. Many proteins critical to mitochondrial function such
as cytochrome oxidase subunits I, III and IV accumulate upon protea-
some inhibitor treatment [23]. Recently the cytosolic 26S proteasome
has been implicated in the turnover of uncoupling proteins 2 and 3
(UCP2 and UCP3) [17,18]. In these studies it was shown that inhibition
of the cytosolic proteasome blocked UCP2 and UCP3 degradation. A
reconstituted, cell-free system to study proteasome dependent degra-
dation of UCP2 and 3 was also used to show that the cytosolic protea-
some is capable of degrading both proteins with a half-life similar to
the half-life observed in cycloheximide treated cells. Furthermore, a
role for mitochondrial membrane potential was implicated in the
unfolding and degradation of inner-membrane mitochondrial proteins
in these studies.
In light of the fact that turnover of UCP2 and UCP3 has been linked
to ubiquitinylation and cytoplasmic proteasome activity and that
phosphorylation has been identiﬁed as a ﬂag for ubiquitinylation,
we decided to investigate whether UCP1 can be ubiquitinylated and
whether the cytoplasmic proteasome plays a role in turnover of UCP1.2. Materials and methods
2.1. Animals
Wistar rats were a mix of males and females aged between 10 and
12 weeks. They were housed at 25±1 °C in individually ventilated
cages. All animals were allowed free access to food [Harlan 2018 Teklad
Global 18% (w/w) Protein Rodent diet] and water and a 12-h light/dark
cycle was in place. All rats were killed by CO2 asphyxiation. Ethical
consent for use of the rats was granted by the Bio Resources Ethics
Committee, Trinity College Dublin through the Department of Health
(Ireland), under guidelines detailed in the Cruelty to Animals Act
(1876) as amended by the European Communities regulations 2002
and 2005.2.2. Mitochondrial protein determination
Quantiﬁcation of protein concentrations in mitochondria and cell
samples was performed using the bicinchoninic acid assay (BCA)
method of Smith et al. [26] described in Dlaskovà et al. [27].
2.3. Isolation of mitochondria
Mitochondria were isolated following standard methods involving
disruption of tissue followed by differential centrifugation. BAT mito-
chondria were prepared from the interscapular region of the rat as
described in Dlaskovà et al. [27]. Thymus mitochondria were prepared
by the method of Chappell [28] as described in Carroll et al. [3].
2.4. Immunoprecipitation of proteins
To solubilize proteins prior to immunoprecipitation, mitochondria
were lysed in modiﬁed radioimmunoprecipitation (RIPA) buffer
(50 mM Tris, 150 mM NaCl, 2 mM EDTA) containing 1% NP-40,
25 mM 2-chloroacetamide and freshly added protease inhibitors
(AEBSF, aprotinin, bestatin, E-64, leupeptin, pepstain A, potassium
vanadate and potassium iodide), at 4 °C for 20 min with gentle
rotation. Lysateswere centrifuged at 14,000×g in a pre-cooled centrifuge
for 15 min to remove aggregates. Lysates were next pre-cleared with
protein A- or G-conjugated Sepharose® beads (as appropriate) for
15 min at 4 °Cwith gentle rotation. The beads were removed by centrifu-
gation at 4000×g for 3 min in a pre-cooled centrifuge. Pre-cleared lysates
were incubated with the appropriate primary antibody overnight at 4 °C
with gentle rotation. The next morning the cleared lysates were mixed
with pre-equilibrated protein A or G-conjugated beads for 2 h at 4 °C.
The beadswere pelleted andwashed 3×10min in RIPA buffer containing
protease inhibitors and 0.1% NP-40. The bound material was eluted by
heating the beads in 2× sample buffer for 5 min at 95 °C and the samples
were subjected to gel electrophoresis to separate the immunoprecipitated
proteins.
2.5. Sodiumdodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
and immunoblotting
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed by the method of Laemmli [29], using a mini-
PROTEAN® 3 CELL (Bio-Rad) with a 5% stacking and a 12% resolving
gel. Pre-stained molecular weight markers (Fisher cat No:BP3601))
were used as standards. Samples were electrophoresed at 200 V for
45 min. Immunoblotting was performed as described in Cunningham
et al. [30].
2.6. Coomassie brilliant blue R-250 staining of proteins in SDS-PAGE gels
Following SDS-PAGE, the Laemmli gels were stained using Coo-
massie Brilliant Blue R-250 according to the method of Laemmlli [29].
2.7. In-gel trypsin digestion
Brieﬂy, gel slices weremanually cut into 1 mmcubes and de-stained
using (50/45/5 (v/v/v) methanol/water/acetic acid) prior to reduction
(10 mM dithiothreitol, Sigma) for 30 min at room temperature and
alkylation (100 mM 2-chloroacetamide, Sigma) for 30 min at room
temperature. Modiﬁed sequencing grade porcine trypsin solution
(30 μL of 20 ng/μL, Promega, Madison, WI) was added to the gel slices
at an enzyme/protein ratio of 1:50 and then digestion was performed
for 16 h at 37 °C. The peptides were extracted out of the gel slices
with 400 μL (50/40/10 (v/v/v) acetonitrile/water/formic acid). The sam-
ples were then Speed Vac centrifuged to dryness and stored at−80 °C
until analysis by mass spectrometry.
116-
85-
45-
kDa
30-
18-
I.B: UCP 1
Fig. 1. UCP1 protein bands with molecular masses greater than 32 kDa can be detected
from BAT mitochondria incubated with a ubiquitin conjugating system. BAT (500 μg/ml)
mitochondria were incubated at 37 °C in a non-ionic medium (250 mM sucrose 5 mM
Tris–HCl, pH 7.4, 1 mM EGTA) containing an ATP regenerating system (1 mM ATP,
10 mMphosphocreatine and 20U/ml creatine kinase) and a ubiquitin conjugating system
(100 μg ubiquitin, 1.4 μg fraction 1 and 1.4 μg fraction 2 from Calbiochem cat#662096) as
described inAzzu and Brand [34]. Samples (5 μg)were taken at 0, 12, 24 and 36 h and sub-
jected to SDS-PAGE. Immunoblotting was performed using an anti-UCP1 antibody (1/500
dilution, Sigma, cat #U6382).
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An Ultimate Nano-HPLC (LC-Packings/Dionex Canada, Oakville, ON,
Canada) coupled to an Applied Biosystems/MDS Sciex QSTAR Pulsar I
Hybrid Quadrupole-TOF LC-MS/MS Mass Spectrometer (Concord, ON,
Canada) was used to perform the LC-MS/MS analyses. Samples were
rehydrated in 40 μL (2% (v/v) acetonitrile, 0.1% (v/v) formic acid) and
1 μL was injected via a FAMOS Autosampler (LC-Packings/Dionex
Canada, Oakville, ON, Canada). The samples were directly injected
onto an in-house prepared nano-analytical column (150 mm×75 μm
column diameter; Michrom Bioresources, Inc, Auburn, CA, USA)
containing Magic C18AQ resin [31]. The nano-column was connected
to a 20 μm I.D. emitter tip (New Objective Inc., Woburn, MA, USA)
positioned at the oriﬁce plate of the mass spectrometer with spray
established by applying a tip voltage of 1900 V pre-nano column via a
platinum wire nano-tee high voltage connection. The following 1 hr
HPLC analytical separation was performed at 300 nL/min (5 min 100%
Solvent A (98% v/v water/2% acetonitrile, 0.1% formic acid), 25 min linear
gradient from 5% to 28% solvent B (98% (v/v) acetonitrile, 0.1% (v/v)
formic acid), 11 min linear gradient from 28% to 43% solvent B, 80%
(v/v) solvent B over 2 min and held for 2 min at 80% (v/v) solvent B.
The gradient was then ramped down over 2 min and re-equilibrated at
100% (v/v) solvent A for 13 min before the next injection. Mass spectra
were acquired collecting a 1 sec TOFMS survey scan of 400–1600m/z
followed by two 2.5 sec product ion scans 100–1500m/z. MS/MS spectra
were acquired in a data dependent manner selecting the top 2 most
intense eluting ions in the 400–1,600m/z range with a 2+ to 5+ charge
state. Following selection for MS/MS analysis, precursor ions were
excluded from selection forMS/MS analysis for 180 sec. A rolling collision
energy for fragmentation was selected based on the precursor ion mass
using the following formula 0.05m/z+5 V. Mass spectrometer parame-
ters used were as follows: Declustering potential setting of 50, focusing
potential setting of 220, curtain gas setting of 25 and CAD gas setting of
8 with Nitrogen in the collision cell.
2.9. Determining the half-life of UCP1 in thymocytes
Thymocytes were isolated from mouse thymi by standard
methods and seeded at 2×106 cells/ml in fully supplemented RPMI-
1640 medium, containing 10% (w/v) heat-inactivated foetal bovine
serum. The cells were incubated at 37 °C in a 5% CO2 in air mixture.
Thymocytes were treated with 10 μg/mL cycloheximide at time
point zero to arrest protein translation. At various time points there-
after, they were pelleted by centrifugation. The resulting cell pellets
were washed twice in ice cold PBS and lysed on ice for 30 min with
lysis buffer. Insoluble material was removed by centrifugation.
2.10. Data analysis parameters
MS/MS data were searched by centroiding with Analyst QS 1.1
Mascot script 1.6 b25 (MDS Sciex) to create the Mascot generic format
ﬁle (mgf) for data base searching. The mgf ﬁles were searched against
Uniprot-Swissprot database 20090225 (410518 sequences; 148080998
residues) allspecies, rodentia and rat IPI databases with the following
parameters: ﬁxed: carbamidomethyl (C) variable: deamidated (NQ), ox-
idation (M), propionamide (C), GlyGly (K), LeuArgGlyGly (K) as variable
modiﬁcations, peptide mass tolerance±0.3 amu, fragment mass toler-
ance±0.15 amu and trypsin enzyme speciﬁcitywith 2missed cleavages.
3. Results
In order to determine whether UCP1 has the potential to be ubiqui-
tinylated, BAT mitochondria were incubated with puriﬁed ubiquitin in
a ubiquitin conjugating system. This conjugating system has been used
successfully as part of an in vitro proteasome degradation system in
studies on mitochondrial UCP2 and UCP3 turnover [17,18]. Using anantibody speciﬁc to UCP1 (Fig. 2D), the immunoblot in Fig. 1 shows
that from 12 h and up to 36 h after incubating the mitochondria in
the ubiquitin conjugating system at 37 °C, UCP1 can be detected at
45–120 kDa, higher than its native molecular mass (32 kDa). It thus
appears that UCP1 can be ubiquitinylated in this in vitro system.
In light of the aforementioned in vitro data, we set out to deter-
mine whether in vivo ubiquitinylation of UCP1 could be detected in
freshly isolated mitochondria. Fig. 2A depicts immunoblots on BAT
and thymus mitochondrial proteins immunoprecipitated using an
anti-ubiquitin antibody. Fig. 2B depicts immunoblots on BAT and
thymus mitochondrial proteins immunoprecipitated using either an
anti-UCP1 antibody or an anti-adenine nucleotide transporter (ANT)
antibody. ANT is present in all mitochondria and like UCP1, is a
member of the mitochondrial transporter family. The immunoblots
shown in Fig. 2A illustrate that UCP1 reactive bands can be detected
in anti-ubiquitin immunoprecipitates from thymus mitochondria
(lane 1) and BAT mitochondria (lane 2). Those in Fig. 2B illustrate
that ubiquitin reactive protein bands can be detected in anti-UCP1
immunoprecipitates from thymus mitochondria (lane 3) and BAT
mitochondria (lane 5). An immunoprecipitation using an anti-ANT
antibody in thymus and BAT mitochondria shows that ubiquitiny-
lated ANT is not detectable in BAT mitochondria (lane 6), but may
be present in small amounts in thymus mitochondria (lane 4). Thus
we have evidence from isolated BAT and thymus mitochondria that
UCP1 is ubiquitinylated in vivo. Control experiments demonstrate
(a) that the anti-ANT antibodies pulls down protein of mass equiva-
lent to the mass (33 kDa) of ANT in BAT and thymus mitochondria
(Fig. 2C, lanes 7 and 8), complimenting observations demonstrated
in other studies [32,33], (b) the anti-UCP1 antibody (Sigma) is
selective for UCP1 over other UCPs and mitochondrial transporters
as it only detects protein of appropriate mass (32 kDa) in BAT mito-
chondria from wild-type but not UCP1 knock-out mice (Fig. 2D,
lanes 9 and 10) and the presence and abundance of mitochondria in
lanes 9 and 10 are indicated by the presence of anti-PDH antibodies.
The protein bands most likely due to heavy chain and light chain IgG
from the immunoprecipitations are indicated (Figs. 2b and C). We next
exploredUCP1 turnover in vivo by determiningwhether there is involve-
ment of the cytoplasmic proteasome in the regulation of UCP1 protein
abundance. Fig. 3 is an immunoblot of cell lysates obtained frommature
brown adipocytes which were treated with the proteasome inhibitor
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Fig. 2. Immunoblots illustrating the immunoprecipitation of UCP1 using an anti-ubiquitin antibody and the immunoprecipitation of ubiquitinated proteins using an anti-
UCP1 antibody. BAT and thymus mitochondria were isolated from Wistar rats. Immunoprecipitations were performed using anti-UCP1 (5 μg, Sigma, cat#U6382), anti-Ubiquitin
(5 μg, Santa Cruz, cat#sc-8017) and anti-ANT(5 μg, Santa Cruz, cat#H188), as indicated. Immunoprecipitates were subjected to SDS-PAGE and western blotting using anti-UCP1
(1/500, Sigma, cat #U6382),anti-ubiquitin (1/500, Santa Cruz, cat #sc-8017) and anti-ANT(1/10000, Santa Cruz, cat#H188) antibodies for immunodetection as indicated. (A) demon-
strates UCP1 reactive bands detected in anti-ubiquitin immunoprecipitates from thymusmitochondria (lane 1) and BAT mitochondria (lane 2). (B) demonstrates ubiquitin reactive pro-
tein bands detected in anti-UCP1 immunoprecipitates from thymus mitochondria (lane 3) and BAT mitochondria (lane 5). Immunoprecipitation using an anti-ANT antibody in thymus
and BAT mitochondria demonstrates ubiquitinylated ANT is not detectable in BAT mitochondria (lane 6), but may be present in small amounts in thymus mitochondria (lane 4). The
protein bands most likely due to heavy chain and light chain IgG from the immunoprecipitations are indicated, (C) demonstrates that anti-ANT antibodies pull down protein of mass
equivalent to the mass (33 kDa) of ANT in BAT and thymus mitochondria (lanes 7 and 8) and the protein bands most likely due to heavy chain IgG from the immunoprecipitations
are indicated, (D) demonstrates that the anti-UCP1 antibody (Sigma) is selective for UCP1 over other UCPs and mitochondrial transporters as it only detects protein of appropriate
mass (32 kDa) in BAT mitochondria from wild-type but not UCP1 knock-out mice (lanes 9 and 10). The presence and abundance of mitochondria in lanes 9 and 10 are indicated by
the presence of anti-PDH antibodies.
A B
Fig. 3. UCP1 protein levels in mature brown adipocytes are sensitive to proteasome inhi-
bition. Brown adipocytes were isolated and differentiated from C57BL6 mice and treated
with the proteasome inhibitor MG132 (+) or the vehicle DMSO (−) for 12 h. Cell lysates
were collected and subjected to SDS-PAGE and immunoblotting using anti-UCP1 (1/500,
Sigma, cat #U6382), anti-β-Actin (1/1000, Millipore, cat #MAB1501) and anti-ubiquitin
(1/500, Santa Cruz, cat #sc-8017) for immunodetection as indicated. (A) demonstrates
an immunoblot detecting ubiquitinylated protein in cell lysates from brown adipocytes
treated with and without proteasome inhibitor and (B) demonstrates an immunoblot
detecting UCP1 in cell lysates from brown adipocytes treated with and without protea-
some inhibitor.
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Fig. 3A, treatment of mature brown adipocytes with proteasome inhibi-
tor increased the amount of ubiquitinylated proteins present in cell ly-
sates. As shown in Fig. 3B, the UCP1 protein levels were augmented in
the presence of proteasome inhibition. We conclude from these data
that the cytoplasmic proteasome is involved in UCP1 turnover in
brown adipocytes.
We investigated the turnover process inmore detail using an in vitro
ubiquitin conjugating/proteasome degradation system. Fig. 4 illustrates
a time course over 48 h for the degradation of UCP1 in isolated BAT
mitochondria in the presence of a reconstituted in vitro ubiquitin
conjugating/proteasome degradation system and the requisite ATP
regenerating system. Omission of any of the components (namely,
succinate, ubiquitin or the 26S proteasome) appeared to reduce the
degree of degradation of UCP1, but not signiﬁcantly (Fig. 4A). The pres-
ence of the protonophore, triﬂuoromethoxyphenylhydrazone (FCCP),
also reduced the degree of degradation of UCP1 in the in vitro ubiqui-
tin conjugating/proteasome degradation system (Fig. 4B). Fig. 4C
Illustrates representative immunoblots from the experiments de-
scribed in Fig. 4A. The data show that UCP1 degradation is most
obvious in the in vitro ubiquitin conjugating/proteasome degrada-
tion system in the presence of succinate for isolated brown adipose
tissue mitochondria over 48 h. Fig. 4D illustrates representative im-
munoblots from the experiments described in Fig. 4B. The data
show that UCP1 degradation in the in vitro ubiquitin conjugating/
proteasome degradation system with isolated brown adipose tissue
mitochondria is dependent on membrane potential over 48 h.
We also investigated UCP1 degradation using the in vitro ubiquitin
conjugating/proteasome degradation system with isolated mitochon-
dria from thymus. Although the half-life of UCP1 in BAT has been well
documented and is known to be between 20 and 72 h [11,12], the
half-life of UCP1 in thymocytes has not been determined. Therefore,in order to establish a meaningful time frame for the ubiquitinylation
studies in thymus, we ﬁrst determined the half-life of UCP1 in thymo-
cytes. Freshly isolated thymocytes were isolated from mouse thymus,
seeded and treated with cycloheximide at time point zero to arrest
protein translation. At 1, 3, 6 and 8 h time points, cells were pelleted,
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Fig. 4. Reconstitution of UCP1 degradation in brown adipose tissue mitochondria by a ubiquitin–proteasome system. BAT mitochondria were isolated as described and an in vitro
degradation assay for UCP1 was undertaken essentially as described by Azzu and Brand [34]. For each assay BAT mitochondria (500 μg/mL) were incubated with an ATP regenerat-
ing system, consisting of 1 mM ATP, 10 mM phosphocreatine, 20 U/mL creatine kinase, 2 mM MgCl2 and 0.1% (w/v) defatted bovine serum albumin. Where indicated 20 mM suc-
cinate, 20 μM FCCP, ubiquitin mix (35 μg ubiquitin, 1.4 μg fraction 1, 1.4 μg fraction 2 from Calbiochem cat. #662096) and 5 μg 26S proteasome fraction were added to the assay.
Mitochondria were incubated at 37 °C and samples (10 μg) were removed at the relevant time point, subjected to SDS-PAGE and immunoblotting using an anti-UCP1 antibody
(1/500, Sigma) for immunodetection. Densitometry was performed using scion imaging to determine relative intensity at each time point. (A) illustrates a comparison of UCP1 deg-
radation in the presence of the indicated components of a ubiquitin-proteasome degradation system and (C) illustrates typical immunoblots from each assay. (B) illustrates a com-
parison of UCP1 degradation by the reconstituted ubiquitin-proteasome degradation system in the presence and absence of FCCP and (D) illustrates typical immunoblots in the
presence and absence of FCCP.
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UCP1 levels diminished to near zero after 8 h. We estimated the half-
life of UCP1 in thymocytes to be ~3 h. We established a time course
over 8 h for the degradation of UCP1 with isolated thymus mitochon-
dria in the presence of a reconstituted in vitro ubiquitin conjugating/
proteasome degradation system and ATP regenerating system. The re-
sults are shown in Fig. 6. Omission of any of the components (succi-
nate, ubiquitin or the 26S proteasome) reduced the degradation of
UCP1 signiﬁcantly (Fig. 6A). FCCP also reduced the degradation of
UCP1 (Fig. 6B). Figs. 6C and D show representative immunoblots
from the experiments described in Figs. 6A and B, respectively. These
data show that UCP1 degradation is detectable in the in vitro ubiquitin
conjugating/proteasome degradation system with isolated thymus mi-
tochondria over 8 h and is dependent on membrane potential.
As a control for the observed degradation of UCP1 inmitochondria,we
measured the level of UCP1 in BAT and thymus mitochondria in the
absence of the proteasome to determine whether the degradation of
UCP1 was proteasome dependent. Fig. 7 illustrates that without the
proteasome, UCP1 levels were stable when isolated BAT mitochondria
were incubated at 37 °C for 48 h (Fig. 7A) or when isolated thymusmito-
chondriawere incubated at 37 °C for 8 h (Fig. 7B). Thus, therewasnodeg-
radation of UCP1 in mitochondria without the cytoplasmic proteasome
under in vitro experimental conditions equivalent to those in Figs. 4 and 6.
During cold-acclimation, brown adipose tissue activity increases
commensurate with an increase in the abundance of UCP1 [2]. We
therefore determined whether there was any increase in UCP1 positive
protein bands at masses greater than the mass of native UCP1 in brown
adipose tissue mitochondria isolated from cold-acclimated animals.
SDS-PAGE and immunoblotting were used to determine the levels of
UCP1 in BAT mitochondria isolated from cold-acclimated rats and ratshoused at room temperature. The results are shown in Fig. 8. Proteins
withmolecular masses greater than 32 kDa were detected with greater
abundance in BAT mitochondria isolated from cold-acclimated rats
compared to BAT mitochondria isolated from rats housed at room tem-
perature. As expected, UCP1 detected at 32 kDa was also in greater
abundance in BAT mitochondria isolated from cold-acclimated rats.
The loading control, pyruvate dehydrogenase-alpha-E1, showed that
equal amounts of BAT mitochondria were used in each of the two
lanes of the blot. In order to conﬁrm that the higher molecular mass
protein bands prominent as a result of cold-acclimation were indeed
UCP1, we immunoprecipitated (with an anti-UCP1 antibody) protein
from the brown adipose tissue mitochondria from cold acclimated
animals and separated them with a view to identifying them by mass
spectrometry. Fig. 9A shows a colloidal Coomassie Brilliant Blue
G-250 stained gel of immunoprecipitated samples. The four selected
UCP1-immunoprecipitated bands with molecular masses greater than
32 kDa, and which were also detectable using an anti-ubiquitin anti-
body (Fig. 9B), were excised and subjected to in-gel digestion with
trypsin, prior to LC MS/MS analysis. The position of any contaminating
IgG in these samples was also highlighted by immunoblotting (Fig. 9B).
Table 1 gives a summary of UCP1 peptide coverage from the LC MS/MS
analysis of the trypsin digested bands. The data clearly demonstrate
there was a common peptide sequence (IGLYDTVQEYFSSGR) consis-
tent with UCP1 in all bands. We conclude that all these high molecular
weight (ubiquitin-positive) protein bands contain UCP1.
4. Discussion
In this study, we show, for the ﬁrst time, that UCP1 can be ubiquiti-
nylated (in vitro and in vivo) and is degraded by the cytoplasmic
Table 1
Sequences of UCP1 peptides identiﬁed by mass spectroscopy in the excised high molec-
ular mass bands (1 to 4) indicated in Fig. 8.
Peptide from band
number
Sequence Residue nos. Percent coverage
of UCP1
1 K.LYSGLPAGIQR.Q 74–84 12%
1 R.VIATTESLSTLWK.G 163–175
1 R.IGLYDTVQEYFSSGR.E 93–107
2 R.VIATTESLSTLWK.G 163–175 9%
2 R.IGLYDTVQEYFSSGR.E 93–107
3 R.MQAQSHLHGIKPR.Y 141–153 9%
3 R.IGLYDTVQEYFSSGR.E 93–107
4 R.YKGVLGTITTLAK.T 55–67 13%
4 R.VIATTESLSTLWK.G 163–175
4 R.IGLYDTVQEYFSSGR.E 93–107
A
B
Fig. 5. Half-life of UCP1 in the thymus. (A) Thymocytes were isolated into fully supple-
mented RPMI medium at 2×106 cells/ml, then treated with 10 μg/mL cycloheximide to
arrest protein synthesis, harvested at the times shown and immunoblotted for UCP1.
Membranes were re-blotted for β-actin as a control (the lower immunoblot shows
an example (B)). Fifty micrograms of cell lysate was used per lane. (C) Cell UCP1
content (expressed as a ratio of β-actin by densitometry) normalised to time point
zero—as a function of time after cycloheximide treatment. Values are means±S.E.M.
from n=3 mitochondrial preparations.
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be ubiquitinylated, indeed polyubiquitinylated, using an in vitro ubiqui-
tin conjugating system (Fig. 1). In addition, UCP1 was also determined
to be ubiquitinylated in vivo in mitochondria isolated from both BAT
and thymus tissues (Fig. 2). These data are consistent with those of
Azzu et al. [17] and Azzu and Brand [34] who demonstrated that UCP2
and UCP3 were ubiquitinylated in cultured and transfected cells. Inter-
estingly, we observed that a related inner membrane transporter, the
adenine nucleotide transporter (ANT), appeared not to be ubiquitiny-
lated in brown adipose tissue mitochondria but may be ubiquitinylated
to a small extent in thymusmitochondria (Fig. 2). This observation sug-
gests that ubiquitinylationmay not be a general feature of all mitochon-
drial carrier proteins. A similar observation noted that UCP2 was
degraded by the proteasome in INS-1E cells, whereas this was not the
case for the ANT in INS-1E cells [34,35]. Thus ubiquitinylation may re-
ﬂect protein turnover due to adaptation as exempliﬁed by the UCPs,
as opposed to constitutive protein turnover as exempliﬁed by ANT.
One of themain functions of ubiquitinylation is to target the protein
for degradation by the 26S proteasome [20,21]. To test whether polyu-
biquitinylation of UCP1 could be linked to degradation by the protea-
some, we pharmacologically inhibited the cytosolic 26S proteasome
in mature brown adipocytes and measured the amount of UCP1 in
the resulting cell lysates (Fig. 3). The amount of ubiquitinylated
proteins present in cell lysates of mature brown adipocytes increased,
as did the abundance of UCP1 present in treated cells. We thus can con-
clude that the cytoplasmic proteasome is involved in UCP1 turnover in
brown adipocytes. Equivalent observations using the same strategy
and proteasome inhibitor concluded that the cytoplasmic proteasome
was important for UCP2 turnover in INS-1E cells [34]. The half-life of
UCP1 in BAT mitochondria is relatively long with a range of half-lives
reported in the literature from 20 h for acute adrenergically stimulated
brown adipocytes to 30 h reported for UCP1 expressed in CHO cells
[11] and 72 h for chronic adrenergically stimulated brown adipocytes
[12]. Due to this long half-life, sufﬁcient incubation time with the
proteasome inhibitor was needed to ensure that adequate turnover of
UCP1 has occurred and thus to determine whether proteasome inhibi-
tion has had any effect. We also tried to use a more speciﬁc proteasome
inhibitor, epoxomicin [36], to study the effect of proteasome inhibition
on UCP1 degradation. However, mature brown adipocytes were not
viable after 12 h in the presence of epoxomicin and so the levels of
UCP1 protein were not possible to determine accurately.
Wewere able to demonstrate that UCP1 degradationwas detectable
using an in vitro ubiquitin conjugating/proteasome degradation system
with isolated brown adipose tissue mitochondria over 48 h and that
degradation was dependent on ubiquitin, the proteasome, and a mem-
brane potential (Fig. 4). We were also able to demonstrate that UCP1
was stable in mitochondria over the time-frame of the experiment in
the absence of the proteasome (Fig. 7) and thus degradation was not
occurring from within the mitochondria. Reassuringly, our time-frame
for detection of degradation of UCP1 with brown adipose tissuemitochondria (Fig. 4) was consistent with the half-life of UCP1 in
brown adipocytes, which is estimated to be between 20 and 72 h
[11,12].
Clearly, knowledge of the half-life of UCP1 is useful when deciding
the time scale for using the in vitro ubiquitin conjugating/proteasome
degradation system. We thus ﬁrst had to determine the half-life of
UCP1 in thymocytes. Extrapolation from cycloheximide treated cells
gave an estimated half-life of ~3 h for UCP1 in thymocytes (Fig. 5).
Consequently, we showed that UCP1 degradation was detectable with
isolated thymus mitochondria over a period of 8 h. In an analogous
situation to that in brown adipose tissue mitochondria, degradation
was dependent on the presence of ubiquitin, the proteasome, and a
membrane potential (Fig. 6). We were also able to demonstrate that
UCP1was stable in mitochondria over the timeframe of the experiment
in the absence of the proteasome, again showing that degradation was
not occurring fromwithin the mitochondria (Fig. 7). Again, reassuring-
ly, the time-frame for detection of degradation of UCP1 in thymusmito-
chondria (Fig. 6) was consistent with the half-life of UCP1 in
thymocytes (Fig. 5). A point of particular interest was the observation
of the tissue speciﬁc differential in the timeframe for degradation of
the same protein, UCP1. It is interesting that ubiquitinylation, which is
normally associated with proteins of relatively rapid turnover, like
that of UCP1 in thymocytes, is associated with the longer timeframe
turnover of UCP1 in BAT. However, it does make sense that UCP1 in
BAT is ubiquitinylated in that it is a protein associated with physiologi-
cal adaptation. Similar in vitro degradation experiments were per-
formed for UCP2 in INS-1E cell lysates [34] for UCP3 in C2C12
myotubule lysates and for UCP3 in skeletal muscle mitochondria [17].
In analagous ﬁndings, UCP2/3 degradation was dependent on the pres-
ence of ubiquitin, the proteasome, and amembrane potential. Half-lives
of between 0.5 and 4 h were reported for UCP2 [35] and UCP3 [18],
similar to those for UCP1 in thymus. Previous studies have also
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Fig. 6. UCP1 protein levels are stable in isolated thymus mitochondria incubated at 37 °C for 8 h. Thymus mitochondria were isolated as described and an in vitro degradation assay
for UCP1 was undertaken essentially as described by Azzu and Brand [34]. For each assay thymus mitochondria (500 μg/ml) were incubated with an ATP regenerating system, con-
sisting of 1 mM ATP, 10 mM phosphocreatine, 20 U/mL creatine kinase, 2 mMMgCl2 and 0.1% (w/v) defatted bovine serum albumin. Where indicated 20 mM succinate, 20 μM FCCP,
ubiquitin mix (35 μg ubiquitin, 1.4 μg fraction 1, 1.4 μg fraction 2 from Calbiochem cat. #662096) and 5 μg 26S proteasome fraction were added to the assay. Mitochondria were
incubated at 37 °C and samples (10 μg) were removed at the relevant time point, subjected to SDS-PAGE and immunoblotting using an anti-UCP1 antibody (1/500, Sigma) for
immunodetection. Densitometry was performed using scion imaging to determine relative intensity at each time point. (A) illustrates a comparison of UCP1 degradation in the
presence of the indicated components of a ubiquitin-proteasome degradation system and (C) illustrates typical immunoblots from each assay. (B) illustrates a comparison of
UCP1 degradation by a reconstituted ubiquitin-proteasome degradation system in the presence and absence of FCCP and (D) illustrates typical immunoblots in the presence and
absence of FCCP. * indicates pb0.01.
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proteasome degradation system for UCP2 and 3 [17,34], data which is
consistent with our observations. The less dramatic effect of FCCP on
the rate of degradation of UCP1 in BAT mitochondria compared to thatA) BAT mitochondria
32 kDa
I.B: UCP 1
B) Thymus mitochondria
32 kDa-
(hrs)
I.B: UCP 1
Fig. 7. UCP1 protein levels are stable in isolated BAT and thymus mitochondria incubat-
ed at 37 °C in the absence of a proteasome conjugating system. Freshly isolated
mitochondria were incubated at 37 °C in medium (250 mM sucrose, 5 mM Tris–HCl,
pH 7.4) and 1 mM EGTA) plus an ATP regenerating system consisting of 1 mM ATP,
10 mM phosphocreatine, 20 U/ml creatine kinase, 2 mMMgCl2 and 0.1% (w/v) defatted
bovine serum albumin, but in the absence of a proteasome conjugating system. At
speciﬁed time points, samples were taken, boiled in 2× gel loading buffer and sub-
jected to SDS-PAGE and immunoblotting using a UCP1 antibody (1/500, Sigma) for
immunodetection.in thymus mitochondria (Figs. 4 and 6) may be due to the length of
time for which themitochondria were incubated, i.e. 48 h for BATmito-
chondria while only 8 h for thymus mitochondria. Isolated mitochon-
dria incubated at 37 °C for 48 h would be unlikely to be completely
coupled, and therefore the effect of uncoupling by FCCP may be under-
stated, due to the mitochondria in the control system (minus FCCP)
being partially/completely uncoupled also. The differences in incubation
time may also explain the differences in the degradation of UCP1 in the
presence of a full ubiquitin-proteasome degradation system in BAT and
thymus mitochondria (Figs. 4 and 6). The lesser effectiveness of a com-
plete ubiquitin–proteasome degradation system in BAT mitochondria
may be due to the presence of mitochondria which are partially
uncoupled. Nonetheless, it must be emphasized that UCP1 degradation
in BAT and thymus mitochondria is proteasome dependent. There is no
signiﬁcant degradation of UCP1 in the absence of proteasome, even in
the presence of ATP (Fig. 7).
During cold acclimation, the thermogenic activity of BAT rises, as
animals require heat production to maintain their body temperature
[1,2]. Cold-acclimation increases UCP1 abundance and might well
increase the proportion of UCP1 that is ubiquitinylated and turned-
over. Our experiments showed that cold-acclimation increased the
abundance of the higher molecular mass-UCP1 positive protein bands
associated with mitochondria isolated from brown adipose tissue
which presumably reﬂects a greater degree of UCP1 turnover (Fig. 8).
We also observe UCP1 positive protein of mass less than 32 kDa follow-
ing cold acclimation and equivalent UCP1 positive protein bands were
associated with the in vitro ubiquitin conjugating system with mito-
chondria isolated from BAT (Fig. 1). Taken together, these observations
suggest that the UCP1 positive protein bands are as a result of UCP1
degradation. Consistent with this observation is our previously
reported observation that UCP1 is phosphorylated on serine 51 and
either serine at positions 3 or 4 [14]. In addition, we were able to
IB: UCP 1
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Fig. 8. BAT mitochondria isolated from cold acclimated rats contain greater amounts of
UCP1 with a molecular weight >32 kDa compared to BAT mitochondria isolated from
rats housed at room temperature. BAT mitochondria were isolated from cold acclimated
rats and rats housed at room temperature. Mitochondria (1 μg per lane) subjected to SDS-
PAGE as immunoblotting blotting using anti-UCP1 (1/500, Sigma) and anti-PDH-E1-
alpha (1/500, Mitosciences, cat #MSPO3) for immunodetection as indicated.
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from cold-acclimated rats, was signiﬁcantly greater than that on
UCP1 from animals kept at room temperature [14]. The role of this ser-
ine phosphorylation of UCP1 is not known, but covalent modiﬁcation
by phosphorylation has been identiﬁed as amarker for ubiquitinylation
[15,16].
In order to conﬁrm that the higher molecular mass-UCP1 antibody-
detected protein bands observed inmitochondria from cold-acclimated
animals were indeed UCP1, we used a UCP1-speciﬁc antibody to im-
munoprecipitate proteins from those mitochondria. The gel-separated
protein, in the higher molecular mass bands, was shown to be ubiqui-
tinylated (Fig. 9). Tryptic digestion followed by mass spectrometric
analysis of the resulting peptides from four of these high molecular
mass protein bands showed that UCP1 was present in all bands116-
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B
e
Anti-UCP 1 Immunoprecipitation
1
2
3
4
A
Fig. 9. UCP1 immunoprecipitation followed by colloidal Coomassie Brilliant BlueR-250 staining
was performed with anti-UCP1 (5 μg, Sigma) antibody. The proteins that were “pulled-down”
indicated protein bands (1 to 4)were excised and theproteins subjected to in-gel trypsinization
membranes and immunoblotted for ubiquitin (anti-ubiquitin 1/500, Santa Cruz, cat #sc-8017)(Table 1). Therefore we conclude that all these higher protein bands
contain UCP1 and that they run higher than 32 kDa on SDS-PAGE gels
because they are ubiquitinylated.
The mechanism by which ubiquitinylated mitochondrial proteins
are exported to the cytosol, where the bulk of the proteasome ma-
chinery is located, is still under debate. The process whereby targeted
proteins are retro-translocated through one or two mitochondrial
membranes is unknown. However, a similar pathway through one
membrane occurs in the endoplasmic reticulum (ER) called the
ERAD pathway (ER-associated degradation pathway) [37]. This
pathway involves ubiquitinylation of target proteins followed
by retro-translocation across the membrane and subsequent degra-
dation by the proteasome in the cytosol. As already mentioned,
inner-mitochondrial and matrix proteins would require retro-
translocation through two membranes, so extra steps in any putative
mitochondrial associated degradative pathway would be required.
Karbowski et al. [38] proposed such a pathway for mitochondrial
outer membrane-associated proteins, and this proposal was extended
to explain mitochondrial inner membrane proteins in a model by
Azzu and Brand [34].
Azzu et al. [35] have proposed a model whereby a mitochondrial
inner membrane protein is ubiquitinylated by an E3 ligase and un-
folded from the mitochondrial inner membrane by a process which
is possibly ATP or membrane potential dependent. At the outer mem-
brane the ubiquitinylated protein is recognized by the proteasome,
whereby it extracts the protein and degrades it.
In conclusion, the data presented in this manuscript provide evi-
dence that UCP1 in BAT and thymus mitochondria can be ubiquitiny-
lated in vitro and in vivo and requires the cytoplasmic proteasome for
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